The stem cell research community will be coming together this March in Connecticut for the international symposium on stem cell research. The symposium will feature world-class scientific speakers and leaders in stem cell bioethics, commercialization, and public policy. From up-to-the-minute discussions on commercialization, public policy, and bioethics, StemCONN 07 will provide scientists, legislators, and others with a fascinating view of the state of stem cell research today and its potential to advance new therapies.
On March 27, J. Mark Waxman, partner and chair of Foley’s Health Care Industry Team, will be participating in the session entitled, “Preparing for human Embryonic Stem Cell (hESC) Review in a Politically Charged Environment.”
Other participants in this session include: